Message from our CEO
As the developments involving the novel coronavirus (COVID-19) continue to evolve, we continue to monitor and implement recommendations from local, national and global health organizations. Profound’s top priorities are the health and safety of our employees, customers, and the communities in which we live and work. To that end, we have put new proactive, precautionary measures in place, such as virtual business meetings and clinical training programs, with a view to help keep everyone safer and help flatten the spread curve of COVID-19.
At the same time, we remain deeply committed to accomplishing our mission of developing and marketing customizable, incision-free therapies for the ablation of diseased tissue. Everyone at Profound is healthy, well-connected, and productive; and all of the Company’s programs, initiatives, and activities are operating close to normal. Please don’t hesitate to interact. We are here for you, and we’re in this together.